'Act now for a sustainable future', JP Morgan's European healthcare boss tells UK firms
This article was originally published in Scrip
Executive Summary
Is the UK's biopharmaceutical sector in danger of "missing the boat"? That's the warning from Cathrin Petty, co-head of the healthcare group covering the EMEA region at JP Morgan, who believes that the healthcare business community needs to take advantage of the positive investment climate in the UK in the next two to three years, or potentially lose out for decades to come.